Proteomic insight into the pathogenesis of CAPN5-vitreoretinopathy
暂无分享,去创建一个
G. Velez | A. Bassuk | S. Tsang | V. Mahajan | Angela S. Li | Jing Yang
[1] G. Velez,et al. VCAN Canonical Splice Site Mutation is Associated With Vitreoretinal Degeneration and Disrupts an MMP Proteolytic Site , 2019, Investigative ophthalmology & visual science.
[2] A. Bassuk,et al. PROGRESSION OF SCOTOPIC SINGLE-FLASH ELECTRORETINOGRAPHY IN THE STAGES OF CAPN5 VITREORETINOPATHY. , 2018, Retinal cases & brief reports.
[3] Daniel A. Machlab,et al. Personalized Proteomics for Precision Health: Identifying Biomarkers of Vitreoretinal Disease , 2018, Translational vision science & technology.
[4] J. J. McAnany,et al. Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface , 2018, Free radical biology & medicine.
[5] Brian Brooks,et al. A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay , 2018, Cold Spring Harbor molecular case studies.
[6] Rova Virgana,et al. The Superoxide Dismutase Mimetic TEMPOL and Its Effect on Retinal Ganglion Cells in Experimental Methanol-Intoxicated Rats , 2018, Ophthalmology and Therapy.
[7] C. Tomaz,et al. iTRAQ Quantitative Proteomic Analysis of Vitreous from Patients with Retinal Detachment , 2018, International journal of molecular sciences.
[8] C. Grimm,et al. The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease. , 2018, Investigative ophthalmology & visual science.
[9] Daniel A. Machlab,et al. Proteomic analysis of the human retina reveals region-specific susceptibilities to metabolic- and oxidative stress-related diseases , 2018, PloS one.
[10] G. Velez,et al. Therapeutic drug repositioning using personalized proteomics of liquid biopsies. , 2017, JCI insight.
[11] G. Velez,et al. Personalized Proteomics in Proliferative Vitreoretinopathy Implicate Hematopoietic Cell Recruitment and mTOR as a Therapeutic Target. , 2017, American journal of ophthalmology.
[12] A. Bassuk,et al. Calpain-5 gene expression in the mouse eye and brain , 2017, BMC Research Notes.
[13] L. Bernal,et al. Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions. , 2017, Immunobiology.
[14] H. Guan,et al. Increased levels of alphaB‐crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor , 2017, Clinical & experimental ophthalmology.
[15] A. D. den Hollander,et al. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment , 2017, Molecular immunology.
[16] L. Stein,et al. Reactome pathway analysis: a high-performance in-memory approach , 2017, BMC Bioinformatics.
[17] G. Velez,et al. Proteomic analysis of elevated intraocular pressure with retinal detachment , 2017, American journal of ophthalmology case reports.
[18] H. Sorimachi,et al. Calpain research for drug discovery: challenges and potential , 2016, Nature Reviews Drug Discovery.
[19] Juan Antonio Vizcaíno,et al. The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition , 2016, Nucleic Acids Res..
[20] G. Velez,et al. Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses , 2016, Investigative ophthalmology & visual science.
[21] Alexander G Bassuk,et al. Precision Medicine: Personalized Proteomics for the Diagnosis and Treatment of Idiopathic Inflammatory Disease. , 2016, JAMA ophthalmology.
[22] F. Wang,et al. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy. , 2016, Discovery medicine.
[23] Martin Eisenacher,et al. PRIDE Inspector Toolsuite: Moving Toward a Universal Visualization Tool for Proteomics Data Standard Formats and Quality Assessment of ProteomeXchange Datasets , 2015, Molecular & Cellular Proteomics.
[24] José A. Dianes,et al. 2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..
[25] Fitsum Tamene,et al. Quantitative Proteomics Analysis of Vitreous Humor from Diabetic Retinopathy Patients. , 2015, Journal of proteome research.
[26] Katherine J. Wert,et al. CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model. , 2015, Human molecular genetics.
[27] V. Perez,et al. Immune mechanisms in inflammatory and degenerative eye disease. , 2015, Trends in immunology.
[28] V. Mahajan,et al. Proteomic Insight into the Molecular Function of the Vitreous , 2015, PloS one.
[29] A. Bassuk,et al. Structural Modeling of a Novel CAPN5 Mutation that Causes Uveitis and Neovascular Retinal Detachment , 2015, PloS one.
[30] V. Mahajan,et al. Proteomic landscape of the human choroid-retinal pigment epithelial complex. , 2014, JAMA ophthalmology.
[31] N. I. Shehata,et al. Tempol, a Superoxide Dismutase Mimetic Agent, Ameliorates Cisplatin-Induced Nephrotoxicity through Alleviation of Mitochondrial Dysfunction in Mice , 2014, PloS one.
[32] Katherine J. Wert,et al. Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina. , 2014, Human molecular genetics.
[33] V. Mahajan,et al. Translational vitreous proteomics , 2014, Proteomics. Clinical applications.
[34] J. Handa,et al. T Cells and Macrophages Responding to Oxidative Damage Cooperate in Pathogenesis of a Mouse Model of Age-Related Macular Degeneration , 2014, PloS one.
[35] J. Yates,et al. Protein analysis by shotgun/bottom-up proteomics. , 2013, Chemical reviews.
[36] Junhai Han,et al. Neurexin Regulates Visual Function via Mediating Retinoid Transport to Promote Rhodopsin Maturation , 2013, Neuron.
[37] Anushya Muruganujan,et al. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees , 2012, Nucleic Acids Res..
[38] V. Sheffield,et al. Calpain-5 Mutations Cause Autoimmune Uveitis, Retinal Neovascularization, and Photoreceptor Degeneration , 2012, PLoS genetics.
[39] M. Humphries,et al. Opticin Exerts Its Anti-angiogenic Activity by Regulating Extracellular Matrix Adhesiveness , 2012, The Journal of Biological Chemistry.
[40] V. Perez,et al. Molecular medicine: Defence against oxidative damage , 2011, Nature.
[41] G. Karakiulakis,et al. Vitreous and serum levels of vascular endothelial growth factor and platelet‐derived growth factor and their correlation in patients with non‐proliferative diabetic retinopathy and clinically significant macula oedema , 2011, Acta ophthalmologica.
[42] J. B. Lopes de Faria,et al. Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats. , 2010, Investigative ophthalmology & visual science.
[43] P. Butler,et al. Calcium-activated Calpain-2 Is a Mediator of Beta Cell Dysfunction and Apoptosis in Type 2 Diabetes* , 2009, The Journal of Biological Chemistry.
[44] E. Petricoin,et al. Activated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response. , 2009, Archives of ophthalmology.
[45] G. Karakiulakis,et al. Vitreous and Serum Levels of Platelet-Derived Growth Factor and Their Correlation in Patients with Proliferative Diabetic Retinopathy , 2009, Current eye research.
[46] F. Liu,et al. Vitreous proteomic analysis of proliferative vitreoretinopathy , 2008, Proteomics.
[47] L. Claesson‐Welsh,et al. alphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. , 2008, Blood.
[48] T. Köcher,et al. Costimulation induced phosphorylation of L‐plastin facilitates surface transport of the T cell activation molecules CD69 and CD25 , 2007, European journal of immunology.
[49] P. Stanga,et al. X-linked retinoschisis: an update , 2006, Journal of Medical Genetics.
[50] Nektarios Tavernarakis,et al. Proteolytic mechanisms in necrotic cell death and neurodegeneration , 2005, FEBS letters.
[51] V. Perez,et al. Elevated Levels of Interleukin 6 in the Vitreous Fluid of Patients with Pars Planitis and Posterior Uveitis: The Massachusetts Eye & Ear Experience and Review of Previous Studies , 2004, Ocular immunology and inflammation.
[52] Justine R. Smith,et al. Prevalent use of complementary and alternative medicine by patients with inflammatory eye disease , 2004, Ocular immunology and inflammation.
[53] M. Campbell,et al. PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.
[54] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[55] E. Mazzon,et al. Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo , 2002, British journal of pharmacology.
[56] H. Wässle,et al. Glutamate Receptors in the Rod Pathway of the Mammalian Retina , 2001, The Journal of Neuroscience.
[57] Patrick L. McGeer,et al. Inflammation, autotoxicity and Alzheimer disease , 2001, Neurobiology of Aging.
[58] H. Wässle,et al. Diversity of glutamate receptors in the mammalian retina , 1998, Vision Research.
[59] I. Fleming,et al. The role of calpain in diabetes-associated platelet hyperactivation. , 2010, Advances in pharmacology.